The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.

Eurofins Medical Device Services North America, part of a global network of over 20 medical device testing laboratories and a leading medical device solutions partner, recently launcheda GMPPFAS ...

The contract research organization will launch an expanded ISO 18562 gas pathway testing program and ISO 10993-18 particulate ...

TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of ...

STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the availability of its robust In Vitro Micronucleus Test service to meet the ...

Good Laboratory Practice certification expands company's ability to support medical device manufacturers in meeting the complex demands of international regulatory frameworks "Our customers are ...

Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...

Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...

Launched in 2021, Boston-based Eyebot places its vision testing technology in popular sites like schools, grocery stores, and ...

DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- Globally, the medical industry is undergoing a major ...

There are all kinds of specialist services provided by telemedicine – telepsychiatry, teleradiology, tele-ICU, just to name a few. But there's a unique telemedicine service that has been growing that ...